Zimmer Biomet Holdings, Inc. (ZBH) Balance Sheet

The balance sheet has expanded modestly over the period, with total assets increasing by approximately 6% from 2024Q1 to 2026Q2. However, total debt has risen by about 29% over the same period, suggesting that growth is increasingly debt-financed. This trend may indicate a strategic shift towards leveraging the balance sheet for acquisitions or shareholder returns, but it also raises leverage levels, which investors should monitor.

The debt-to-equity ratio has increased from 0.46 to 0.59 over the ten quarters, driven by a $1.7B increase in total debt while equity remained relatively flat. This suggests that the company is taking on more debt, possibly for acquisitions or buybacks, which could strain cash flow if interest rates rise. However, the absolute leverage remains moderate compared to peers like Stryker (D/E 0.73), and the company's cash flow generation appears sufficient to service the debt.

Goodwill has increased from $8.8B in 2024Q1 to $9.9B in 2026Q2, reflecting ongoing acquisition activity. This concentration in intangible assets poses a risk of impairment if expected synergies fail to materialize. The relatively low PPE net of $2.2B indicates an asset-light manufacturing model, but the heavy goodwill load warrants close monitoring of acquisition performance.

Equity has remained stable around $12.5-12.7B, with retained earnings increasing by $1.5B over the period. This suggests that while the company is returning capital to shareholders via buybacks and dividends, it is still retaining a significant portion of earnings to support growth. The stability in equity despite buybacks indicates that earnings are being reinvested effectively, though the impact of stock-based compensation on dilution should be considered.

The current ratio has declined from a peak of 2.44 in 2025Q1 to 1.69 in 2026Q2, and cash balances have fallen sharply from $1.4B to $410M. This suggests that the company has been deploying cash for acquisitions, buybacks, and debt repayment, reducing its buffer against short-term shocks. While the current ratio remains above 1, the trend warrants monitoring, especially given the company's high debt levels.